Deere — The farm equipment maker earned $1.08 per share for its fiscal fourth quarter, well above estimates of 75 cents. Revenue was light of estimates, however, and Deere did say equipment sales will drop about seven percent for fiscal 2016 and 11 percent for the current quarter compared to a year earlier.

Hormel — The food producer announced a two-for-one stock split, with a record date of Jan. 26, 2016.

Baxalta — The drug maker's stock is adding to gains, following yesterday's Reuters report that European drug maker Shire was preparing a new bid for Baxalta. Shire was rebuffed in an overture to Baxalta earlier this year.

HP Inc., Hewlett Packard Enterprises — The offspring of the old Hewlett-Packard issued the final earnings report prior to HP's split into two separate companies earlier this month. The "original" HP missed estimates by 4 cents with adjusted quarterly profit of 93 cents per share, with revenue also shy of estimates. Separately — printer and computer maker HP gave light guidance for the current quarter, as did Hewlett-Packard Enterprise.

TiVo — TiVo earned 6 cents per share for its latest quarter, 2 cents below estimates, though revenue was above forecasts as was the digital video recorder maker's current quarter guidance. TiVo also reported record subscriber additions, but its bottom line was impacted by higher costs.

Guess — Guess reported quarterly profit of 15 cents per share, 4 cents above estimates, with revenue matching forecasts. The apparel retailer was able to beat forecasts despite a falling sales situation made worse by a stronger dollar. However, Guess did raise the lower end of its full-year profit forecast.

Hilton Worldwide — Hilton disclosed a data breach related to customer credit and debit card payments, and the hotel chain has launched an investigation to see how far the breach has spread.

Wal-Mart Stores — The retailer may have engaged in misconduct in Brazil, according to The Wall Street Journal quoting people familiar with a U.S. investigation. The case involves alleged foreign bribery in that market.

BioMarin Pharmaceutical — The drug maker's experimental muscle disorder drug got a negative opinion from a U.S. Food and Drug Administration panel, which said efficacy data was not persuasive enough. The full FDA will decide on whether to approve the drug at a Dec. 27 meeting.

Yahoo — The company's outlook has been cut to "negative" by Standard & Poor's based on the company's performance. S&P's credit rating for Yahoo remains at BB+.

Syngenta — The maker of agricultural chemicals is in the process of examining various options, according to a Swiss newspaper report quoting company chairman Michel Demare. Syngenta had previously fought off a $47 billion takeover bid from Monsanto.

Toyota Motor — The automaker will replace Takata airbag inflators that it had previously deemed safe in 1.6 million cars in Japan. That follows a passenger injury earlier this year in a Nissan vehicle which contained an airbag inflator that had been previously inspected.

Sony — Sony said its PlayStation 4 video game console had passed the 30 million mark in sales, two years after its launch. This version of the PlayStation has sold faster than any of its predecessors.

Blackstone — Blackstone is close to a deal to sell four Los Angeles office towers for more than $1 billion, according to The Wall Street Journal. Separately, the New York Post reports that Blackstone sold the London Hotel in New York to the Abu Dhabi Investment Authority for $382 million.

EMC, VMWare — Shareholders in the two companies want changes to the deal that sells EMC to computer maker Dell, according to Re/code, before they will vote for it. EMC currently owns a majority stake in VMWare, with both companies to be controlled by Dell after the deal goes through.